sales@angenesci.com
Login | Register
logo
Structures Search
Home Nitriles Quinoxaline-2-carbonitrile

Quinoxaline-2-carbonitrile

CAS No.:
7483-33-2
Catalog Number:
AG003HXC
Molecular Formula:
C9H5N3
Molecular Weight:
155.1561
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
100mg
96%
In Stock USA
United States
$125
- +
1g
96%
In Stock USA
United States
$344
- +
5g
96%
In Stock USA
United States
$1013
- +
10g
96%
In Stock USA
United States
$1500
- +
Product Description
Catalog Number:
AG003HXC
Chemical Name:
Quinoxaline-2-carbonitrile
CAS Number:
7483-33-2
Molecular Formula:
C9H5N3
Molecular Weight:
155.1561
MDL Number:
MFCD12403337
IUPAC Name:
quinoxaline-2-carbonitrile
InChI:
InChI=1S/C9H5N3/c10-5-7-6-11-8-3-1-2-4-9(8)12-7/h1-4,6H
InChI Key:
IVYZWJPQNNZOHV-UHFFFAOYSA-N
SMILES:
N#Cc1cnc2c(n1)cccc2
Properties
Complexity:
205  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
155.048g/mol
Formal Charge:
0
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
155.16g/mol
Monoisotopic Mass:
155.048g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
49.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.3  
Literature
Title Journal
Novel Phenazine 5,10-Dioxides Release OH in Simulated Hypoxia and Induce Reduction of Tumour Volume In Vivo. ISRN pharmacology 20110101
Quinoline-2-carbonitrile. Acta crystallographica. Section E, Structure reports online 20100901
Quinoxaline-2-carbonitrile. Acta crystallographica. Section E, Structure reports online 20100101
Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs. Bioorganic & medicinal chemistry 20090215
Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives. Bioorganic & medicinal chemistry 20030515
Anti-Mycobacterium tuberculosis agents derived from quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide. Arzneimittel-Forschung 20020101
Antimycobacterial activity of new quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives. Die Pharmazie 20010301
Properties